
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants
Author(s) -
J.M. Merino Arribas,
Alfonso Carmona Martínez,
Michael Horn,
Xavier M. Pérez Porcuna,
María del Carmen Otero Reigada,
Josep Marès Bermúdez,
Fernando Centeno,
Mariano Miranda,
María José Méndez,
Miguel Ángel García Cabezas,
Wittermann Christoph,
Gerhard Bleckmann,
Thomas Fischbach,
Devayani Kolhe,
Marie Van der Wielen,
Yaela Baine
Publication year - 2018
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002061
Subject(s) - reactogenicity , medicine , conjugate vaccine , diphtheria , immunogenicity , vaccination , hib vaccine , pediatrics , booster dose , pneumococcal conjugate vaccine , haemophilus influenzae , hepatitis b , immunology , immunization , antibody , antibiotics , microbiology and biotechnology , streptococcus pneumoniae , biology
This study evaluated the immunogenicity and reactogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus virus-Haemophilus influenzae type b vaccine (DTPa-HBV-IPV/Hib) and a 10-valent pneumococcal conjugate vaccine (PHiD-CV) coadministered with a quadrivalent meningococcal conjugate vaccine (MenACWY-TT) in infants/toddlers.